Daniela S. Thommen - Concepedia

Author

Daniela S. Thommen

Also Known As

D THOMMEN, D Thommen, D. Thommen, D.S. Thommen, Daniela S Thommen, Daniela S. Thommen, Daniela Thommen, Daniela S Thommen, Désirée Thommen, Thommen, Daniela Stefanie

202

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Oncode Institute University Hospital of Basel The Netherlands Cancer Institute University of Basel Leiden University Medical Center

About

Daniela S. Thommen is an author at Oncode Institute specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	3K
2	Engineering	1	1	17
3	Health Sciences	1	1	21
4	Natural Sciences	1	1	16
5	Allergy	1	1	16

Daniela S. Thommen

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade Daniela S. Thommen, Viktor H. Koelzer, Petra Herzig, Nature Medicine Cancer ImmunosurveillanceNon-small-cell Lung CancerPd-1 BlockadeMedicineImmunology	2018	1.1K
Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors Daniela S. Thommen, Jens Schreiner, Philipp Müller, Cancer Immunology Research Increased DysfunctionT-regulatory CellImmunologyMultiple Inhibitory ReceptorsImmune Checkpoints	2015	378
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer Paula Voabil, Marjolein de Bruijn, Lisanne M. Roelofsen, Nature Medicine Pd-1 BlockadeMedicineTumor ImmunityImmune Checkpoint InhibitorTumor Targeting	2021	336
Trastuzumab emtansine (T-DM1) renders HER2 <sup>+</sup> breast cancer highly susceptible to CTLA-4/PD-1 blockade Philipp Müller, Matthias Kreuzaler, Tarik A. Khan, Science Translational Medicine Breast OncologyImmunologyRegulatory T CellsCell PolarizationImmunotherapeutics	2015	328
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells Michal A. Stanczak, Shoib Sarwar Siddiqui, Marcel P. Trefny, Journal of Clinical Investigation Radiation OncologyCancer ImmunosurveillanceT CellsNormal T CellsT-regulatory Cell	2018	293
Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy Victoria S. Pelly, Agrin Moeini, Lisanne M. Roelofsen, Cancer Discovery	2021	225
IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer Olga Blomberg, Lorenzo Spagnuolo, Hannah Garner, Cancer Cell Cancer ImmunosurveillanceAutoimmune DiseaseImmunologyImmune Checkpoint InhibitorAutoimmunity	2022	192
Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ Mirjam E. Hoekstra, Laura Bornes, Feline E. Dijkgraaf, Nature Cancer Cancer ImmunosurveillanceImmunologyImmune RegulationTumor ImmunityImmunologic Mechanism	2020	141
Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4 <sup>+</sup> T cells Sarah Dimeloe, Patrick M. Gubser, Jordan Loeliger, Science Signaling	2019	87
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy Marcel P. Trefny, Nicole Kirchhammer, Priska Auf der Maur, Nature Communications	2023	81

Page 1